One Grand Central Place
Suite 4600 60 East 42nd Street
New York, NY 10165
United States
212 949 4319
https://www.luciddx.com
Sector(s):Â Healthcare
Industry:Â Medical Devices
Full Time Employees:Â
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Lishan Aklog M.D. | Chairman & CEO | N/A | N/A | 1966 |
Dr. Sanford D. Markowitz M.D., Ph.D. | Cofounder & Strategic Advisor, Member of the Medical Advisor Board | 41.26k | N/A | N/A |
Mr. Dennis M. McGrath CPA | CFO, Pres & Sec. | N/A | N/A | 1957 |
Dr. Joseph Willis M.D. | Cofounder, Strategic Advisor & Member of Medical Advisory Board | N/A | N/A | N/A |
Dr. Amitabh Chak M.D. | Cofounder, Strategic Advisor & Member of Medical Advisory Board | N/A | N/A | N/A |
Mr. Shaun O'Neill M.B.A. | Exec. VP & COO | N/A | N/A | 1982 |
Richard D. Yazbeck | Chief Technology Officer | N/A | N/A | N/A |
Dr. Suman M. Verma M.D., Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Mr. Adrian K. Miller | VP of Investor Relations | N/A | N/A | N/A |
Dr. Brian J. deGuzman M.D. | Chief Compliance Officer | N/A | N/A | 1965 |
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, a esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Lucid Diagnostics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.